The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $19.82

Today's change-0.07 -0.35%
Updated June 19 3:32 PM EDT. Delayed by at least 15 minutes.
 

Spectrum Pharmaceuticals Inc

Nasdaq: SPPI
Last

(U.S.) $19.82

Today's change-0.07 -0.35%
Updated June 19 3:32 PM EDT. Delayed by at least 15 minutes.

Spectrum Pharmaceuticals Inc down (U.S.)$0.07

Spectrum Pharmaceuticals Inc is lower today, dropping (U.S.)$0.07 or 0.35% to (U.S.)$19.82. Shares have lost 0.70% over the last five days, but have gained 4.59% over the last year to date. This security has outperformed the S&P 500 by 184.23% during the last year.

Key company metrics

  • Open(U.S.) $19.60
  • Previous close(U.S.) $19.89
  • High(U.S.) $19.86
  • Low(U.S.) $19.33
  • Bid / Ask(U.S.) $19.81 / (U.S.) $19.83
  • YTD % change+4.59%
  • Volume1,369,931
  • Average volume (10-day)1,503,697
  • Average volume (1-month)1,547,776
  • Average volume (3-month)1,568,808
  • 52-week range(U.S.) $6.50 to (U.S.) $23.50
  • Beta1.97
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.54
Updated June 19 3:32 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.37%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2018Q4/2017Q3/2017Q2/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201803/31/2018Dec 31, 201712/31/2017Sep 30, 201709/30/2017Jun 30, 201706/30/2017
Revenue30293634
Total other revenue--------
Total revenue30293634
Gross profit24172421
Total cost of revenue7111213
Total operating expense56705253
Selling / general / administrative24301917
Research & development18221415
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-25-42-15-18
Interest income (expense), net non-operating-1-1-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-16-44-20-20
Income after tax-1610-19-20
Income tax, total0-54-10
Net income-16-29-19-20
Total adjustments to net income--------
Net income before extra. items-1610-19-20
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1610-19-20
Inc. avail. to common incl. extra. items-16-29-19-20
Diluted net income-16-29-19-20
Dilution adjustment--------
Diluted weighted average shares1011008379
Diluted EPS excluding extraordinary itemsvalue per share-0.160.10-0.22-0.26
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.160.10-0.22-0.26